MorphoSys AG
LSE:0NDV
MorphoSys AG
LSE:0NDV
Price:
66.8
EUR
-1.18%
Market Closed
Market Cap:
€959.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
MorphoSys AG
LSE:0NDV
|
DE |
|
K
|
Kingfisher PLC
XMUN:KFI1
|
UK |
|
A
|
Ansell Ltd
DUS:PD1A
|
AU |
|
B
|
Badger Meter Inc
F:33B
|
US |
|
PLDT Inc
XPHS:TEL
|
PH |
|
S
|
Sellas Life Sciences Group Inc
F:RXK3
|
US |
|
Spartan Resources Ltd
ASX:SPR
|
AU |
|
A
|
Abliva AB
F:NTP
|
SE |
|
A
|
Asics Corp
OTC:ASCCF
|
JP |
|
1
|
1911 Gold Corp
OTC:AUMBF
|
CA |
|
K
|
Kongsberg Gruppen ASA
OSE:KOG
|
NO |
|
M
|
Maxell Ltd
F:0H2
|
JP |
|
I
|
Inogen Inc
F:6IO
|
US |
|
Lepidico Ltd
ASX:LPD
|
AU |
|
M
|
Mega Corp Ltd
BSE:531417
|
IN |
|
NexPoint Residential Trust Inc
F:5O4
|
US |
|
K
|
Kerry Group PLC
F:KRZ
|
IE |
|
Platinum Asset Management Ltd
ASX:PTM
|
AU |
|
Hexagon Purus ASA
OTC:HPURF
|
NO |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0NDV's stock price target?
Not Available
0NDV does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for MorphoSys AG?
Projected CAGR
24%
24%
Over the last 8 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 24%.
